Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Statements of Cash Flows (Unaudited)

Condensed Interim Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Aug. 31, 2017
Aug. 31, 2016
Cash Flows from Operating Activities    
Net loss $ (260,803) $ (1,714)
Changes in operating assets and liabilities    
Decrease in prepaid expenses 11,644
Increase in accounts payable 63,142
Increase in accrued liabilities (5,000) 33,307
Net cash (used in)/provided by operating activities (191,017) 31,593
Net cash used in Investing Activities,    
Cash deposited in Trust Account (66,300,000)
Interest income earned on Trust Account (368,766)
Interest withdrawn from Trust Account 280,000
Net cash used in investing activities (88,766) (66,300,000)
Cash Flows from Financing Activities    
Proceeds from sale of Sponsors' shares of common stock 25,000
Proceeds from sale of Public Offering Units, net of offering expenses paid 63,092,898
Proceeds from sale of Private Placement Warrants 3,825,000
Payments to related parties (including loans) (250,535)
Funds from related parties (including loans) 250,535
Net cash provided by financing activities 66,942,898
Net (decrease)/increase in cash (279,783) 674,491
Cash at beginning of period 490,888
Cash at end of period 211,105 674,491
Supplemental disclosure of non-cash investing and financing activities    
Deferred underwriting fees 1,625,000
Common stock issued for additional underwriter compensation 1,000,000
Fair value of unit purchase option issued to underwriter 781,385
Funds from related party promissory notes contributed for extension 303,300
Interest contributed for extension $ 99,236